STMN1 and neuroblastoma: In contrast to overall NB cases and non-MYCN-amplified ones, fewer MYCN-amplified NB cases (n = 8; p = 0.765, Figure 2A, right panel) hindered the drawing of any statistically significant conclusion about the prognostic value of STMN1 expression.